dermatan sulfate has been researched along with Phlegmasia Alba Dolens in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (21.57) | 18.7374 |
1990's | 39 (76.47) | 18.2507 |
2000's | 1 (1.96) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gacko, M; Kowalewski, R; Malkowski, A; Rutkowska, I; Sobolewski, K | 1 |
Hobbelen, PM; Meuleman, DG; Moelker, HC; van Dedem, G | 1 |
Abildgaard, U; Larsen, ML | 1 |
Bucknall, T; Cade, J; Gallus, A; Hepburn, S; Maas, M; Magnani, H; Ockelford, P; Porteous, F; Stevens, J | 1 |
Cziraky, MJ; Egberts, JF; Leibowitz, DA; Magnani, HN; Meuleman, DG; Nicholson, CD; Spinler, SA | 1 |
Cyran, J; Greinacher, A; Scheffold, N | 1 |
Cohen, AT; Cooper, DJ; Das, SK; Edmondson, RA; Kakkar, VV; Melissari, E; Phillips, MJ; Skinner, JA; Thomas, EM | 1 |
Kleinschmidt, S; Seyfert, UT | 1 |
Agnelli, G; Damiani, M; Dupouy, D; Gianese, F; Houin, G; Imbimbo, BP; Saivin, S; Sié, P | 1 |
Cesmeli, S; Davies, AB; Gray, E; Lane, DA; Lormeau, JC | 1 |
Agnelli, G; Boschetti, E; Cosmi, B; Lupattelli, L; Nenci, GG; Radicchia, S; Rinonapoli, E; Veschi, F | 1 |
Barbanti, M; Calanni, F; Colucci, M; Marchi, E; Milani, MR; Semeraro, N | 1 |
Greinacher, A; Kirschke, W; Klement, D; Kniemeyer, HW; Rammos, S; v Kries, R | 1 |
Boneu, B | 2 |
Andreozzi, GM; Di Pino, L; Marchitelli, E; Martini, R; Palazzini, E; Pinto, A; Romeo, S; Signorelli, S; Zamboni, V | 1 |
Agnelli, G; Ascani, A; Nenci, GG; Parise, P; Radicchia, S | 1 |
Cazenave, JP; Chakfe, N; Grunebaum, L; Kretz, JG; Palazzini, E; Wiesel, ML; Zamboni, V | 1 |
Claeys, L; Ehringer, H; Huk, I; Koppensteiner, R; Kyrle, PA; Minar, E; Muhm, M; Polterauer, P; Stümpflen, A | 1 |
Bergqvist, D | 3 |
Turpie, AG | 2 |
Abedinpour, F; Berberich, R; Dumas, R; Egberts, JF; Gregoire, F; Jerkovic, M; Kutnowski, M; Nikolic, I; Woitinas, F; Zoeckler, S | 1 |
Wade, WE | 1 |
Ermacora, P; Lemesle, FG; Lhuillier, P; Marfaing, A; Mebroukine, L; Wolf, M | 1 |
Bergqvist, D; Lindblad, B; Mätzsch, T | 1 |
ten Cate, JW | 1 |
Bachmann, F; Bohnet, J; Breyer, HG; Estoppey, D; Haas, S; Hochreiter, J; Jakubek, H; Leyvraz, P; Mair, J; Sorensen, R | 1 |
Alvarez, R; Fussi, F; Santoro, FM | 1 |
Côte, R; Geerts, W; Gent, M; Ginsberg, JS; Jay, R; Leclerc, J; Levine, MN; Neemeh, J; Powers, PJ; Turpie, AG | 1 |
Boneu, B; Caranobe, C; Crepon, B; Houin, G; Level, M; Lormeau, JC; Petitou, M; Saivin, S; Sie, P | 1 |
Cuppini, S; Gianese, F; Maffei Faccioli, A; Meduri, F; Polistena, P; Prandoni, P; Toniato, A; Zangrandi, F | 1 |
Büller, HR; Hamelynck, KJ; Hoek, JA; Knipscheer, HC; Magnani, HN; Marti, RK; Nurmohamed, MT; ten Cate, H; ten Cate, JW | 1 |
Agnelli, G; Barzi, F; Cosmi, B; Di Filippo, P; Gianese, F; Longetti, M; Lupattelli, L; Ranucci, V; Renga, C; Veschi, F | 1 |
Gerhart, TN; Lee, MA; Robertson, LK; Salzman, EW; Smith, M; Yett, HS | 1 |
Bergqvist, D; Cederholm, C; Faunø, P; Fredin, H; Jensen, LJ; Justesen, T; Karjalainen, P; Kettunen, K; Soimakallio, S; Suomalainen, O | 1 |
Fareed, J; Hoppensteadt, D; Nurmohamed, MT; ten Cate, JW; Walenga, JM | 1 |
Agnelli, G; Cosmi, B; Di Filippo, P; Lupattelli, L; Mosca, S; Nenci, GG; Ranucci, V; Renga, C; Rinonapoli, E | 1 |
Buchanan, MR; Gray, E; Ofosu, FA; Van Ryn-McKenna, J; Weber, E | 1 |
Gallus, A; Magnani, H; Marshall, V; Morris, M; Murphy, W; Nacey, J; Sutherland, P | 1 |
Buchanan, MR; Gray, E; Hirsh, J; Ofosu, FA; Van Ryn-McKenna, J | 1 |
Barrowcliffe, TW; Merton, RE; Thomas, DP | 1 |
Duckert, F; Marbet, GA; Zbinden, B | 1 |
Abbadini, M; Borowska, A; Donati, MB; Maggi, A; Pagella, PG; Pangrazzi, J | 1 |
Merton, RE; Thomas, DP | 1 |
Cade, JF; Chong, BH; Grigg, LE; Kiers, L; Street, PR | 1 |
Cade, JF; Magnani, HN; Westlake, GW; Wood, M | 1 |
8 review(s) available for dermatan sulfate and Phlegmasia Alba Dolens
Article | Year |
---|---|
Glycosaminoglycans: clinical use.
Topics: Dermatan Sulfate; Fibrinolytic Agents; Glycosaminoglycans; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Thrombophlebitis | 1996 |
New antithrombotic agents for the prevention and treatment of deep vein thrombosis.
Topics: Anticoagulants; Antithrombin III; Binding Sites; Chondroitin Sulfates; Clinical Trials as Topic; Dermatan Sulfate; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Multicenter Studies as Topic; Oligosaccharides; Postoperative Complications; Pulmonary Embolism; Recurrence; Thrombin; Thrombophlebitis | 1996 |
New approaches to prevention of deep vein thrombosis.
Topics: Anticoagulants; Antithrombins; Dermatan Sulfate; Humans; Platelet Aggregation Inhibitors; Postoperative Care; Preoperative Care; Thromboembolism; Thrombophlebitis | 1997 |
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature.
Topics: Brain Ischemia; Chondroitin Sulfates; Clinical Trials as Topic; Cost-Benefit Analysis; Dalteparin; Dermatan Sulfate; Drug Combinations; Heparin; Heparitin Sulfate; Humans; MEDLINE; Thrombophlebitis | 1998 |
Modern aspects of prophylaxis and therapy for venous thrombo-embolic disease.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Drug Administration Schedule; Drug Combinations; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1998 |
Glycosaminoglycans in prophylaxis against venous thromboembolism.
Topics: Dermatan Sulfate; Dihydroergotamine; Glycosaminoglycans; Heparin, Low-Molecular-Weight; Humans; Pentosan Sulfuric Polyester; Postoperative Complications; Pulmonary Embolism; Thromboembolism; Thrombophlebitis | 1992 |
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1992 |
Pharmacological and clinical studies with Lomoparan, a low molecular weight glycosaminoglycan.
Topics: Animals; Anticoagulants; Blood Coagulation; Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Evaluation, Preclinical; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Incidence; Mammals; Molecular Weight; Platelet Aggregation; Postoperative Complications; Rabbits; Renal Dialysis; Thrombocytopenia; Thrombophlebitis; Thrombosis | 1991 |
22 trial(s) available for dermatan sulfate and Phlegmasia Alba Dolens
Article | Year |
---|---|
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' Group.
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Elective Surgical Procedures; Female; Gastrointestinal Neoplasms; Glycosaminoglycans; Hematologic Tests; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Lung Neoplasms; Male; Middle Aged; Postoperative Complications; Pulmonary Embolism; Thrombophlebitis | 1993 |
A dose ranging study to evaluate dermatan sulphate in preventing deep vein thrombosis following total hip arthroplasty.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Dermatan Sulfate; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Female; Follow-Up Studies; Hip Prosthesis; Humans; Male; Middle Aged; Phlebography; Postoperative Complications; Pulmonary Embolism; Reference Values; Risk Factors; Thrombophlebitis | 1994 |
Heparin-associated thrombocytopenia (HAT)--still a diagnostic and therapeutical problem in clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arterial Occlusive Diseases; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Female; Gangrene; Heparin; Heparitin Sulfate; Humans; Middle Aged; Phenprocoumon; Platelet Activation; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Recurrence; Systemic Inflammatory Response Syndrome; Thrombocytopenia; Thromboembolism; Thrombophlebitis | 1995 |
Intramuscular dermatan sulfate MF701 in patients with hip fracture: relationship between pharmacokinetics and antithrombotic efficacy.
Topics: Aged; Aged, 80 and over; Anticoagulants; Dermatan Sulfate; Double-Blind Method; Female; Hip Fractures; Humans; Injections, Intramuscular; Male; Middle Aged; Thrombin Time; Thrombophlebitis; Treatment Outcome | 1994 |
Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis.
Topics: Dermatan Sulfate; Double-Blind Method; Evaluation Studies as Topic; False Negative Reactions; Female; Hip Fractures; Hip Prosthesis; Humans; Male; Middle Aged; Phlebography; Plethysmography, Impedance; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Thrombophlebitis | 1993 |
Tolerability and clinical efficacy of desmin in the treatment of superficial thrombovaricophlebitis.
Topics: Adult; Aged; Dermatan Sulfate; Female; Fibrinolytic Agents; Humans; Injections, Intramuscular; Injections, Subcutaneous; Male; Middle Aged; Molecular Weight; Thrombophlebitis; Varicose Veins | 1996 |
Distribution and occlusiveness of thrombi in patients with surveillance detected deep vein thrombosis after hip surgery.
Topics: Aged; Anticoagulants; Dermatan Sulfate; Female; Femoral Vein; Heparinoids; Hip Fractures; Hip Prosthesis; Humans; Incidence; Male; Middle Aged; Phlebography; Plethysmography, Impedance; Popliteal Vein; Postoperative Care; Postoperative Complications; Thrombophlebitis; Ultrasonography | 1996 |
The treatment of deep vein thrombosis with continuous intravenous low-molecular-weight dermatan sulphate (Desmin). A pilot study.
Topics: Adult; Aged; Aged, 80 and over; Dermatan Sulfate; Desmin; Factor Xa; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Thrombophlebitis | 1996 |
A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Thrombophlebitis; Treatment Outcome | 1994 |
Orgaran in hip fracture surgery.
Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Glycosaminoglycans; Hemorrhage; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Incidence; Male; Postoperative Complications; Pulmonary Embolism; Scandinavian and Nordic Countries; Single-Blind Method; Thrombophlebitis; United States; Warfarin | 1992 |
Prevention of deep vein thrombosis following total hip replacement surgery by Orgaran. Summary.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Dihydroergotamine; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Hip Prosthesis; Humans; Incidence; Pulmonary Embolism; Single-Blind Method; Thrombophlebitis; Treatment Outcome | 1992 |
Orgaran in the prevention of deep vein thrombosis in stroke patients.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Hemiplegia; Heparin; Heparinoids; Heparitin Sulfate; Humans; Incidence; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1992 |
Thromboembolic prophylaxis in total hip replacement: a comparison between the low molecular weight heparinoid Lomoparan and heparin-dihydroergotamine.
Topics: Aged; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Dihydroergotamine; Drug Combinations; Female; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hip Prosthesis; Humans; Male; Prospective Studies; Thromboembolism; Thrombophlebitis | 1992 |
A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antithrombin III; Brain Ischemia; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Fibrinolytic Agents; Follow-Up Studies; Glycosaminoglycans; Hemorrhage; Heparin; Heparitin Sulfate; Humans; Male; Middle Aged; Thrombophlebitis | 1992 |
Dermatan sulphate: a safe approach to prevention of postoperative deep vein thrombosis.
Topics: Adult; Aged; Dermatan Sulfate; Female; Fibrinogen; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Male; Middle Aged; Plethysmography, Impedance; Postoperative Complications; Prospective Studies; Thrombophlebitis | 1992 |
Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid.
Topics: Aged; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Female; Glycosaminoglycans; Heparitin Sulfate; Hip Prosthesis; Humans; Male; Middle Aged; Safety; Thrombophlebitis | 1992 |
A randomised, double-blind, placebo-controlled trial of dermatan sulphate for prevention of deep vein thrombosis in hip fracture.
Topics: Aged; Dermatan Sulfate; Double-Blind Method; Drug Monitoring; Female; Hip Fractures; Humans; Male; Middle Aged; Risk Factors; Thrombophlebitis | 1992 |
Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Blood Loss, Surgical; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparinoids; Heparitin Sulfate; Hip Fractures; Humans; Iodine Radioisotopes; Male; Middle Aged; Molecular Weight; Plethysmography; Postoperative Complications; Prevalence; Prospective Studies; Risk Factors; Thrombophlebitis; Warfarin | 1991 |
Thromboprophylaxis in patients with hip fractures: a prospective, randomized, comparative study between Org 10172 and dextran 70.
Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Dextrans; Female; Fibrinolytic Agents; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Hip Fractures; Humans; Male; Single-Blind Method; Thrombophlebitis | 1991 |
Impedance plethysmography in the diagnosis of asymptomatic deep vein thrombosis in hip surgery. A venography-controlled study.
Topics: Aged; Dermatan Sulfate; Evaluation Studies as Topic; Female; Heparin; Hip Joint; Humans; Male; Phlebography; Plethysmography, Impedance; Postoperative Complications; Predictive Value of Tests; Sensitivity and Specificity; Thrombophlebitis | 1991 |
The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomy.
Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Double-Blind Method; Glycosaminoglycans; Hematuria; Hemorrhage; Heparinoids; Heparitin Sulfate; Humans; Male; Middle Aged; Prostatectomy; Randomized Controlled Trials as Topic; Thrombophlebitis; Urologic Diseases | 1989 |
Early clinical experience of a new heparinoid, Org 10172, in prevention of deep venous thrombosis.
Topics: Aged; Aged, 80 and over; Chondroitin Sulfates; Dermatan Sulfate; Factor X; Factor Xa; Female; Glycosaminoglycans; Hemorrhage; Heparitin Sulfate; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Pilot Projects; Research Design; Thoracic Surgery; Thrombophlebitis | 1987 |
22 other study(ies) available for dermatan sulfate and Phlegmasia Alba Dolens
Article | Year |
---|---|
Glycosaminoglycan-degrading enzymes in the varicose vein wall.
Topics: Adult; beta-N-Acetylhexosaminidases; Chondroitin Sulfates; Colorimetry; Dermatan Sulfate; Female; Glycosaminoglycans; Glycoside Hydrolases; Heparitin Sulfate; Humans; Hyaluronic Acid; Iduronidase; Male; N-Acetylgalactosamine-4-Sulfatase; Saphenous Vein; Sulfatases; Thrombophlebitis; Varicose Veins | 2008 |
A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity: a survey of its pharmacological properties in experimental animal models.
Topics: Animals; Blood Coagulation; Blood Platelets; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Male; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Thrombophlebitis | 1982 |
Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.
Topics: Antithrombin III Deficiency; Antithrombins; Chromogenic Compounds; Dermatan Sulfate; Disseminated Intravascular Coagulation; Glycoproteins; Heparin Cofactor II; Humans; Liver Cirrhosis; Oligopeptides; Thrombin; Thrombophlebitis | 1984 |
Danaparoid is not a low-molecular-weight heparin.
Topics: Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Terminology as Topic; Thrombophlebitis | 1994 |
[Intracardial thrombus formation in heparin-associated thrombocytopenia type II].
Topics: Aged; Antibodies; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Chondroitin Sulfates; Coronary Thrombosis; Dermatan Sulfate; Echocardiography; Female; Heparin; Heparinoids; Heparitin Sulfate; Humans; Mitral Valve Stenosis; Partial Thromboplastin Time; Phenprocoumon; Platelet Count; Thrombocytopenia; Thrombophlebitis | 1995 |
Low affinity heparin is an antithrombotic agent.
Topics: Animals; Bleeding Time; Dermatan Sulfate; Disease Models, Animal; Hemorrhage; Heparin; Humans; Metabolic Clearance Rate; Rabbits; Thrombin; Thrombophlebitis | 1994 |
Therapeutic effect of a low molecular weight dermatan sulphate (Desmin 370) in rat venous thrombosis--evidence for an anticoagulant-independent mechanism.
Topics: Animals; Blood Coagulation; Dermatan Sulfate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hemostasis; Male; Molecular Weight; Rats; Rats, Sprague-Dawley; Thrombophlebitis | 1993 |
Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts.
Topics: Adolescent; Chondroitin Sulfates; Dermatan Sulfate; Diagnosis, Differential; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Humans; Male; Platelet Activation; Thrombocytopenia; Thrombophlebitis | 1996 |
Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
Topics: Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dermatan Sulfate; Dose-Response Relationship, Drug; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Infusions, Intravenous; Male; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Thrombocytopenia; Thrombophlebitis | 1997 |
Prophylaxis of venous thromboembolism in stroke patients.
Topics: Cerebrovascular Disorders; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin; Heparin, Low-Molecular-Weight; Heparinoids; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombophlebitis | 1997 |
Ardeparin and danaparoid for prevention of deep vein thrombosis.
Topics: Abdomen; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Humans; Randomized Controlled Trials as Topic; Thrombocytopenia; Thrombophlebitis | 1997 |
[Thrombosis, low-molecular-weight heparin-induced thrombocytopenia and labor].
Topics: Adult; Antithrombin III; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Female; Heparitin Sulfate; Humans; Obstetric Labor Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Thrombocytopenia; Thrombophlebitis; Ultrasonography, Doppler | 1998 |
[Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Topics: Anticoagulants; Chondroitin Sulfates; Dermatan Sulfate; Drug Combinations; Fibrinolytic Agents; Heparin; Heparitin Sulfate; Hirudin Therapy; Hirudins; Humans; Recombinant Proteins; Thrombocytopenia; Thrombophlebitis | 1998 |
Pharmacological profile of a native dermatan sulfate.
Topics: Animals; Bleeding Time; Blood Coagulation; Dermatan Sulfate; Disease Models, Animal; Fibrinolysis; Male; Rats; Rats, Wistar; Thrombophlebitis | 1992 |
Antithrombotic activity, bleeding effect and pharmacodynamics of a succinyl derivative of dermatan sulphate in rabbits.
Topics: Animals; Bleeding Time; Blood Coagulation; Dermatan Sulfate; Dose-Response Relationship, Drug; Rabbits; Rats; Succinates; Thrombophlebitis | 1992 |
Effects of sulfated polysaccharides on inhibition of thrombus formation initiated by different stimuli.
Topics: Animals; Chondroitin; Dermatan Sulfate; Factor Xa; Female; Fibrinolytic Agents; Heparin; Male; Pentosan Sulfuric Polyester; Polysaccharides; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis; Thromboplastin | 1989 |
Effects of dermatan sulfate and heparin on inhibition of thrombus growth in vivo.
Topics: Animals; Chondroitin; Dermatan Sulfate; Factor Xa; Female; Fibrin; Heparin; Kinetics; Male; Prothrombin; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis | 1989 |
Relative efficacy of heparin and related glycosaminoglycans as antithrombotic drugs.
Topics: Animals; Dermatan Sulfate; Disease Models, Animal; Dose-Response Relationship, Drug; Factor Xa; Glycosaminoglycans; Heparin; Oligosaccharides; Partial Thromboplastin Time; Rabbits; Serine Proteinase Inhibitors; Thrombin; Thrombophlebitis | 1989 |
[Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].
Topics: Adolescent; Adult; Antithrombins; Dermatan Sulfate; Female; Glycoproteins; Heparin Cofactor II; Humans; Male; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1988 |
Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model.
Topics: Animals; Bleeding Time; Chondroitin; Dermatan Sulfate; Heparitin Sulfate; Male; Rats; Rats, Inbred Strains; Thrombophlebitis; Vena Cava, Inferior | 1987 |
Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
Topics: Animals; Anticoagulants; Chondroitin; Dermatan Sulfate; Fibrinolytic Agents; Heparin; Humans; In Vitro Techniques; Rabbits; Thrombin; Thrombophlebitis | 1987 |
Use of Org 10,172 in the treatment of heparin-induced thrombocytopenia and thrombosis.
Topics: Aged; Chondroitin Sulfates; Dermatan Sulfate; Female; Glycosaminoglycans; Heparin; Heparitin Sulfate; Humans; Thrombocytopenia; Thrombophlebitis | 1986 |